Noranda Aluminum Holding Corporation (NORNQ)

Revance Therapeutics Revenue

In the year 2015, Noranda Aluminum Holding had annual revenue of $1.23B, down -9.37%. Noranda Aluminum Holding had revenue of $240.30M in the quarter ending December 31, 2015, a decrease of -28.52%.

• Revenue: 1.23B
• Revenue Growth: -9.37%
• P/S Ratio: n/a
• Revenue / Employee: 558.23K
• Employees: 2,200
• Market Cap: 10.00

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2015	1.23B	-127.00M	-9.37%
Dec 31, 2014	1.36B	11.60M	0.86%
Dec 31, 2013	1.34B	-51.40M	-3.68%
Dec 31, 2012	1.39B	-164.90M	-10.57%
Dec 31, 2011	1.56B	264.90M	20.46%